Galliprant 60 Mg 30s
Elanco Animal Health |
CA5811030AL

Galliprant 60 Mg 30s

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Galliprant (grapiprant tablets) is the newest active ingredient approved to control the pain and inflammation associated with OA in dogs. Galliprant is part of a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs).

Active Ingredient
Grapiprant – 60mg

Galliprant 60mg is a modern, targeted non-steroidal anti-inflammatory drug (NSAID) designed to control pain and inflammation associated with mild to moderate osteoarthritis in dogs. It contains grapiprant, an EP4 receptor antagonist that offers effective, focused relief with reduced impact on kidney, liver, and gastrointestinal function compared to traditional NSAIDs.
This 60mg strength is commonly prescribed for medium to large dogs, depending on body weight and veterinary assessment.

Key Features
  • Specifically developed for managing canine osteoarthritis pain
  • Targets EP4 prostaglandin receptor involved in pain signalling
  • Once-daily dosing with minimal risk to kidneys and GI system
  • Flavoured, chewable tablets for easy administration
  • Well-tolerated even with long-term use under supervision


Pack Size
30 chewable flavoured tablets (60mg each)

Precautions
Not recommended for use in dogs under 9 months of age or under 3.6kg
Do not use with other NSAIDs or corticosteroids
Monitor for side effects such as vomiting or appetite changes
Use cautiously in dogs with pre-existing liver or kidney conditions
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription